Cargando…

SOX2 as a novel contributor of oxidative metabolism in melanoma cells

BACKGROUND: Deregulated metabolism is a hallmark of cancer and recent evidence underlines that targeting tumor energetics may improve therapy response and patient outcome. Despite the general attitude of cancer cells to exploit the glycolytic pathway even in the presence of oxygen (aerobic glycolysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreucci, Elena, Pietrobono, Silvia, Peppicelli, Silvia, Ruzzolini, Jessica, Bianchini, Francesca, Biagioni, Alessio, Stecca, Barbara, Calorini, Lido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249961/ https://www.ncbi.nlm.nih.gov/pubmed/30466459 http://dx.doi.org/10.1186/s12964-018-0297-z

Ejemplares similares

The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells
por: Andreucci, Elena, et al.
Publicado: (2020)

Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2022)

FDG uptake in cancer: a continuing debate
por: Peppicelli, Silvia, et al.
Publicado: (2020)

Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry
por: Andreucci, Elena, et al.
Publicado: (2022)

Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2019)

The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells
por: Peppicelli, Silvia, et al.
Publicado: (2020)

Anoikis Resistance as a Further Trait of Acidic-Adapted Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2019)

Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies
por: Ruzzolini, Jessica, et al.
Publicado: (2018)

The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
por: Andreucci, Elena, et al.
Publicado: (2018)

uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells
por: Andreucci, Elena, et al.
Publicado: (2022)

EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells
por: Laurenzana, Anna, et al.
Publicado: (2019)

miR-214-Enriched Extracellular Vesicles Released by Acid-Adapted Melanoma Cells Promote Inflammatory Macrophage-Dependent Tumor Trans-Endothelial Migration
por: Andreucci, Elena, et al.
Publicado: (2022)

Inflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasis
por: PEPPICELLI, SILVIA, et al.
Publicado: (2014)

An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy
por: Peri, Sara, et al.
Publicado: (2022)

Cancer Glycolytic Dependence as a New Target of Olive Leaf Extract
por: Ruzzolini, Jessica, et al.
Publicado: (2020)

Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approach
por: Peppicelli, Silvia, et al.
Publicado: (2015)

Nintedanib-αVβ6 Integrin Ligand Conjugates Reduce TGFβ-Induced EMT in Human Non-Small Cell Lung Cancer
por: Andreucci, Elena, et al.
Publicado: (2023)

A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer
por: Ruzzolini, Jessica, et al.
Publicado: (2019)

CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines
por: Biagioni, Alessio, et al.
Publicado: (2021)

Oleuropein-Rich Leaf Extract as a Broad Inhibitor of Tumour and Macrophage iNOS in an Apc Mutant Rat Model
por: Ruzzolini, Jessica, et al.
Publicado: (2021)

uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells
por: Biagioni, Alessio, et al.
Publicado: (2020)

Triazole RGD antagonist reverts TGFβ1-induced endothelial-to-mesenchymal transition in endothelial precursor cells
por: Bianchini, Francesca, et al.
Publicado: (2016)

Regulation of melanoma initiating cells by Hedgehog signaling and SOX2
por: Santini, Roberta, et al.
Publicado: (2014)

Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma
por: Pietrobono, Silvia, et al.
Publicado: (2023)

Oleuropein, a Bioactive Compound from Olea europaea L., as a Potential Preventive and Therapeutic Agent in Non-Communicable Diseases
por: Nediani, Chiara, et al.
Publicado: (2019)

The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy
por: Rovida, Elisabetta, et al.
Publicado: (2014)

The Role of Glycosylation in Melanoma Progression
por: De Vellis, Chiara, et al.
Publicado: (2021)

Nintedanib-Containing Dual Conjugates Targeting α(V)β(6) Integrin and Tyrosine Kinase Receptors as Potential Antifibrotic Agents
por: Bugatti, Kelly, et al.
Publicado: (2022)

Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme
por: Laurenzana, Anna, et al.
Publicado: (2014)

Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts
por: Andreucci, Elena, et al.
Publicado: (2023)

Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions
por: Calorini, Lido, et al.
Publicado: (2010)

p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells
por: Pietrobono, Silvia, et al.
Publicado: (2022)

Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma
por: Pietrobono, Silvia, et al.
Publicado: (2021)

Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors
por: Pietrobono, Silvia, et al.
Publicado: (2018)

Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
por: Pietrobono, Silvia, et al.
Publicado: (2021)

SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
por: Santini, R, et al.
Publicado: (2014)

Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened
por: Pietrobono, Silvia, et al.
Publicado: (2019)

Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits
por: Calvani, Maura, et al.
Publicado: (2016)

Lactate Maintains BCR/Abl Expression and Signaling in Chronic Myeloid Leukemia Cells Under Nutrient Restriction
por: Silvano, Angela, et al.
Publicado: (2022)

Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A “cellular stove” approach to the photoablation of melanoma
por: Margheri, Giancarlo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p2oh25d9all62bvo82p3ctf3ah